Chronic knee pain while awaiting arthroplasty is associated with worsening joint-specific function, health-related quality of life and personal wellbeing, and increased use of opioid analgesia.

Aims: To assess whether chronic knee pain (CKP) influenced health-related quality of life (HRQoL), knee-specific health, wellbeing, and use of opioid analgesia, and identify variables associated with CKP in patients awaiting knee arthroplasty.

Methods: This study included 217 patients (mean age 69.7 years (SD 8.7), 116 female (53%)) who completed questionnaires that included the EuroQol five-dimension questionnaire (EQ-5D) and EuroQol-visual analogue scale (EQ-VAS), Oxford Knee Score (OKS), and wellbeing assessments at six and 12 months after being listed for surgery. Analgesia use at 12 months was also recorded. CKP was defined using the OKS pain score (PS) of ≤ 14 points at 12 months.

Results: At 12 months, 169 patients (77.9%) had CKP. Compared with those without CKP, those with CKP had clinically meaningfully worse HRQoL and knee-specific health at 12 months and were more likely to have a health state worse than death (odds ratio (OR) 29.7, 95% CI 4.0 to 220.2; p < 0.001). The CKP group were more likely to use weak (OR 3.03, 95% CI 1.65 to 7.96; p = 0.001) and strong (OR 11.8, 95% CI 1.58 to 88.88; p = 0.001) opioids for analgesia. The CKP group had worse overall wellbeing with significantly (p < 0.001) lower satisfaction with life, life being worthwhile and happiness, and increased anxiety. The CKP group had a significant (p < 0.001) deterioration in their OKS, OKS-PS, EQ-5D, and EQ-VAS from six to 12 months, which was not observed in the group without CKP. A worse OKS-PS at six months was independently associated with an increased risk of CKP, and a threshold value of < 13 (sensitivity 91.7%, specificity 94.7%) was an excellent discriminator (area under the curve 96.9, 95% CI 94.2 to 99.6; p < 0.001).

Conclusion: Four in five patients had CKP after waiting 12 months, which was associated with deteriorations in HRQoL and knee health, worse wellbeing, and increased opioid analgesia use. The OKS-PS at six months could be used to identify patients at risk of CKP after 12 months of waiting.